Home > Drug Search >
  • company_query: arGEN-X
  •   > 
Drug Filter
Category:
chemistry (8) biology (26)
Status:
Approved (2) Phase Ⅲ (2) Phase Ⅱ (16) Phase Ⅰ (14)
Clinical Stage:
Pending (2) Active (26) Discontinued (4)
Bio-Type:
Vaccine (8) Animal extract (1) Bispecific antibody (2) Other recombinant protein (1) Whole antibody (8) Fab fragment (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Actinic keratosis (AK) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (4) Bladder cancer (1) Breast cancer (2) Rectal cancer (1) Clostridium difficile infection (1) Transplant rejection (1) Gastric cancer (1) Pancreatitis (1) Alcoholic hepatitis (1) Hypercholesterolemia (1) Influenza virus infection (4) Melanoma (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (2) Psoriasis (1) Rheumatoid arthritis (RA) (2) Solid tumours (6) Head and neck cancer (1) Nasopharyngeal cancer (1) Hodgkin lymphoma (1) Colorectal cancer (2) Dermatitis (1) Age-related macular degeneration (AMD) (2) Autistic disorder (1) Contraception (1) Mycosis fungoides (1) Respiratory syncytial virus infection (1) Diffuse large B cell lymphoma (1) Cardiac reperfusion injury (1) hematological malignancies (2) Ebola virus disease (EVD) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top